X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (393) 393
Publication (41) 41
Book Chapter (12) 12
Book Review (4) 4
Patent (4) 4
Conference Proceeding (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (135) 135
index medicus (115) 115
oncology (94) 94
hematology (84) 84
male (72) 72
female (68) 68
middle aged (63) 63
aged (61) 61
multiple myeloma (51) 51
multiple myeloma - drug therapy (46) 46
adult (44) 44
treatment outcome (42) 42
bortezomib (38) 38
aged, 80 and over (37) 37
antineoplastic agents - therapeutic use (34) 34
leukemia, lymphocytic, chronic, b-cell - drug therapy (32) 32
survival (31) 31
cancer (29) 29
thalidomide - analogs & derivatives (27) 27
therapy (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
article (26) 26
rituximab (26) 26
apoptosis (23) 23
recurrence (23) 23
care and treatment (21) 21
thalidomide - therapeutic use (21) 21
abridged index medicus (20) 20
chronic lymphocytic leukemia (20) 20
lenalidomide (20) 20
antineoplastic agents - adverse effects (19) 19
drug therapy (19) 19
leukemia (19) 19
thalidomide - adverse effects (19) 19
multiple myeloma - pathology (18) 18
analysis (17) 17
chemotherapy (17) 17
cll (17) 17
chronic lymphocytic-leukemia (16) 16
dexamethasone (16) 16
diagnosis (16) 16
prognosis (16) 16
thalidomide (16) 16
multiple myeloma - diagnosis (15) 15
lymphoma (14) 14
stem-cell transplantation (14) 14
thalidomide - administration & dosage (14) 14
animals (13) 13
antineoplastic agents - pharmacology (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
disease-free survival (13) 13
expression (13) 13
cell line, tumor (12) 12
dose-response relationship, drug (12) 12
fludarabine (12) 12
risk factors (12) 12
apoptosis - drug effects (11) 11
health aspects (11) 11
lymphomas (11) 11
multiple myeloma - mortality (11) 11
neoplasm staging (11) 11
patient outcomes (11) 11
research (11) 11
trial (11) 11
bcl-2 (10) 10
combination (10) 10
disease progression (10) 10
drug resistance, neoplasm (10) 10
hematology, oncology and palliative medicine (10) 10
ibrutinib (10) 10
leukemia, lymphocytic, chronic, b-cell - mortality (10) 10
multiple-myeloma (10) 10
myeloma (10) 10
proteins (10) 10
antineoplastic agents - administration & dosage (9) 9
hemic and lymphatic diseases (9) 9
initial therapy (9) 9
kaplan-meier estimate (9) 9
multiple myeloma - therapy (9) 9
stem cell transplantation (9) 9
survival analysis (9) 9
transplantation (9) 9
usage (9) 9
activation (8) 8
boronic acids - therapeutic use (8) 8
cells (8) 8
chronic lymphatic leukemia (8) 8
clinical trials as topic (8) 8
dexamethasone - administration & dosage (8) 8
leukemia, lymphocytic, chronic, b-cell - pathology (8) 8
mice (8) 8
monoclonal antibodies (8) 8
multiple myeloma - metabolism (8) 8
open-label (8) 8
patients (8) 8
pyrazines - therapeutic use (8) 8
survival rate (8) 8
adolescent (7) 7
boronic acids - adverse effects (7) 7
cyclophosphamide (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, ISBN 9781605473338, 317
Immunomodulating Drugs for the Treatment of Cancer provides a comprehensive resource for clinicians and researchers regarding immunomodulatory (IMiDs) drugs... 
drug therapy | Adjuvants, Immunologic | Immunotherapy | methods | pharmacology | therapeutic use | immunology | Neoplasms | Biological response modifiers | Cancer
Book
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3494 - 3494
Background: MM is associated with significant morbidity even at the time of presentation and there is ample data to support that MM treatment improves overall... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e14030 - e14030
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5558 - 5558
Abstract INTRODUCTION: Treatment of chronic lymphocytic leukemia (CLL) has expanded significantly with the approval of multiple small molecule inhibitors. This... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1191 - 1191
Abstract Background: We have previously reported on ethnic disparities in outcomes of multiple myeloma (MM) pts (pts) and shown that Hispanics have the... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 2026 - 2026
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S386 - S387
We performed a comprehensive search of the medical literature using PubMed/Medline and EMBASE on September 28, 2018. We extracted data on clinical outcomes... 
Medical research | Anthracyclines | Analysis | Leukemia | Stem cells | Medicine, Experimental | Lymphomas | Transplantation | Drug therapy | Hematopoietic stem cells
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4480 - 4480
Abstract Introduction. In comparison toCLL, single agent clinical efficacy of venetoclax (a Bcl-2 inhibitor; Bcl-2i) in multiple myeloma (MM) has been modest... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1238 - 1238
Abstract Background: Cost of cancer care is projected to reach $173 billion by 2020, a 39% increase from 2010. Several factors including psychiatric (psych)... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3018 - 3018
Abstract Introduction: With approval of Daratumumab (Dara), targeting CD38 has become an attractive therapeutic option for various B cell cancers including WM.... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2761 - 2761
Abstract Background: Mitochondrial activity is critical to maintain a high cellular proliferation especially in drug-resistant clones. Ibrutinib-resistance... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 230 - 230
Abstract Introduction: Despite recent advances in available treatments, chronic lymphocytic leukemia (CLL) remains an incurable disease, and the vast majority... 
Journal Article
ChemMedChem, ISSN 1860-7179, 09/2018, Volume 13, Issue 18, pp. 1853 - 1853
The Front Cover shows the microscope slides of colorectal cancer cells (DLD‐1) treated with two new indole‐based heterocyclic curcuminoids bearing SCN... 
binding affinity | apoptosis | multiple myeloma | curcuminoids | antitumor agents
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2612 - 2624
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1839 - 1839
Abstract Background: Dexamethasone (dex) is an integral part of various anti-myeloma regimens both in the frontline and relapsed/refractory (RR) setting.... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 935 - 935
Abstract Background: The incidence of secondary Acute Lymphoblastic leukemia (sALL) after a preceding first primary solid organ malignancy (1M) is not well... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2917 - 2917
Abstract Background Outcomes for patients with chronic myeloid leukemia (CML) have improved in recent years. Nonetheless, survival disparities persist between... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e17570 - e17570
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.